tiprankstipranks
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Technical Analysis

Compare
648 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Novabay Pharmaceuticals’s (NBY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Novabay Pharmaceuticals is a Buy.
Novabay Pharmaceuticals’s (NBY) 20-Day exponential moving average is 0.66, while Novabay Pharmaceuticals’s (NBY) share price is $0.63, making it a Sell.
Novabay Pharmaceuticals’s (NBY) 50-Day exponential moving average is 0.66, while Novabay Pharmaceuticals’s (NBY) share price is $0.63, making it a Buy.

NovaBay Pharma (NBY) Pivot Points

Feb 26, 2025, 09:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.59
0.60
0.62
0.63
0.65
0.66
0.67
Fibonacci
0.60
0.62
0.62
0.63
0.64
0.65
0.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NovaBay Pharma (NBY) Moving Averages

Feb 26, 2025, 09:48 AM
Period
Simple
Exponential
MA5
0.65Buy
0.65Buy
MA10
0.66Buy
0.66Buy
MA20
0.66Sell
0.66Sell
MA50
0.64Buy
0.66Buy
MA100
0.65Buy
0.79Sell
MA200
1.24Sell
1.50Sell
Novabay Pharmaceuticals’s (NBY) 10-Day exponential moving average is 0.66, while Novabay Pharmaceuticals’s (NBY) share price is $0.63, making it a Buy.
Novabay Pharmaceuticals’s (NBY) 100-Day exponential moving average is 0.79, while Novabay Pharmaceuticals’s (NBY) share price is $0.63, making it a Sell.
Novabay Pharmaceuticals’s (NBY) stock price is $0.63 and Novabay Pharmaceuticals’s (NBY) 50-day simple moving average is 0.64, creating a Buy signal.
Novabay Pharmaceuticals’s (NBY) stock price is $0.63 and Novabay Pharmaceuticals’s (NBY) 100-day simple moving average is 0.65, creating a Buy signal.
Novabay Pharmaceuticals’s (NBY) stock price is $0.63 and Novabay Pharmaceuticals’s (NBY) 200-day simple moving average is 1.24, creating a Sell signal.

NovaBay Pharma (NBY) Technical Indicators

Feb 26, 2025, 09:48 AM
Name
Value
Implied Action
RSI (14)
49.93
Neutral
STOCH (9,6)
34.36
Neutral
STOCHRSI (14)
41.05
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
17.89
Buy
Williams %R
-43.52
Buy
CCI (14)
-60.02
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
55.16
Neutral
ROC
0.00
Sell
Novabay Pharmaceuticals’s (NBY) Relative Strength Index (RSI) is 49.93, creating a Neutral signal.
Novabay Pharmaceuticals’s (NBY) Trend Strength Indicator (ADX) is 17.89, creating a Buy signal.
Novabay Pharmaceuticals’s (NBY) Commodity Channel Index (CCI) is -60.02, creating a Neutral signal.

FAQ

Is NBY a Buy, Hold, or Sell?
Based on NBY’s technical indicators, NBY is a Buy.
    What is NBY’s RSI (14)?
    NBY’s RSI (14) is 49.93, which suggests NBY is a Neutral.
      What is NBY’s MACD?
      NBY’s MACD is >-0.01, which suggests NBY is a Buy.
        What is NBY’s 5-day moving average?
        NBY’s 5-day moving average is 0.65, which suggests NBY is a Buy.
          What is NBY’s 20-day moving average?
          NBY 20-day moving average is 0.66, which suggests NBY is a Sell.
            What is NBY’s 50-day moving average?
            NBY’s 50-day moving average is 0.64, which suggests NBY is a Buy.
              What is NBY’s 200-day moving average?
              NBY’s 200-day moving average is 1.24, which suggests NBY is a Sell.
                What is NBY’s Williams % R (14)?
                NBY’s Williams % R (14) is -43.52, which suggests NBY is a Buy.
                  What is NBY’s CCI (14)?
                  NBY’s CCI (14) is -60.02, which suggests NBY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis